Recently, an increasing number of studies have indicated the association of moyamoya disease with RNF213 variant, a key antimicrobial protein that strengthens the role of infectious or autoimmune stimuli as a contributing factor to MMD onset (2, 6). This evidence concerns the gene RNF213 and multiminicore myopathy.